Special imaging scans for children with neuroblastoma
Part of Cancer clinical trials.
This study tests two special types of imaging scans that look for neuroblastoma tumors. The imaging uses safe radioactive tracers to help doctors better see the cancer and plan treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or younger.
- You must have been diagnosed with neuroblastoma or your doctor must strongly suspect it.
- You need to have a tumor that can be seen on a CT or MRI scan.
- Your blood counts (red cells, white cells, and platelets) must be in a safe range.
- You should not be pregnant or breastfeeding.
- You must not have had high-dose chemotherapy, radiation, or another research treatment in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of targeted radiation treatment for children and adults with neuroblastoma that has come back or not responded to other treatments. The radiation is attached to a substance that seeks out neuroblastoma cells, aiming to destroy them while limiting harm to healthy tissue.
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
This trial uses a special PET scan called 18F-mFBG to take pictures of neuroblastoma tumors. It helps doctors see where the cancer is and whether treatment is working.
This trial tests a new PET scan tracer (18F-MFBG) against the standard SPECT scan (123I-MIBG) to see if it better shows neuroblastoma tumors. It's for children whose cancer has come back or hasn't responded to treatment.
This trial compares two different nuclear medicine scans to see which one best shows where neuroblastoma is in a child’s body. The results may help doctors choose the most helpful scan for planning care.
This trial compares two imaging scans (123I-MIBG and 18F-MFBG) in children with newly diagnosed, high-risk neuroblastoma. The goal is to see if one scan works better to find tumors and guide treatment.
Hear when a new Neuroblastoma (NB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.